Filter by
Selections
November 15, 2021
Arrowhead Collaborator Presents Phase 2b Clinical Data from REEF-1 Study in Patients with Chronic Hepatitis B Infection
Read MoreNovember 12, 2021
Arrowhead Presents Additional Clinical Data on Investigational ARO-HSD Treatment at AASLD Liver Meeting
Read MoreNovember 12, 2021
Arrowhead Presents Additional Clinical Data on Investigational ARO-AAT Treatment at AASLD Liver Meeting
Read MoreNovember 1, 2021
Arrowhead Pharmaceuticals to Participate in Upcoming November 2021 Conferences
Read MoreOctober 25, 2021
Arrowhead Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-C3 for Treatment of Complement Mediated Diseases
Read MoreOctober 12, 2021